Subacromial Injection With Corticosteroid Versus Nonsteroidal Anti-inflammatory Drugs (NSAID) in Shoulder Impingement Syndrome
Injection with corticosteroid is one of the most common non-operative interventions in the treatment of subacromial impingement; however, its use is limited by its potential side effects (e.g. tendon rupture, subcutaneous atrophy, articular cartilage changes). The objective of this study was to compare the efficacy of subacromial injection of triamcinolone compared to injection of ketorolac. Thirty-two patients diagnosed with external shoulder impingement syndrome were included in this double-blinded randomized controlled clinical trial. Each patient was randomized into the Steroid group or NSAID group.
Subacromial Impingement Syndrome
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
|Official Title:||A Double-blind Randomized Controlled Trial Comparing the Effects of Subacromial Injection With Corticosteroid Versus NSAID in Patients With Shoulder Impingement Syndrome|
- UCLA Shoulder Rating Scale [ Time Frame: 4 Weeks ] [ Designated as safety issue: No ]This scoring system consists of subjective assessments of pain, function and satisfaction, as well as objective measurements of active forward elevation and strength in forward flexion.
- Visual Analog Scale [ Time Frame: 4 Weeks ] [ Designated as safety issue: No ]This is a pain scale.
- Range of Motion [ Time Frame: 4 Weeks ] [ Designated as safety issue: No ]Shoulder Range of Motion was assessed with a hand held goniometer
|Study Start Date:||September 2000|
|Study Completion Date:||September 2005|
|Primary Completion Date:||September 2005 (Final data collection date for primary outcome measure)|
Test Group: This group was given subacromial injections of Ketorolac.
Active Comparator: Steroid
This group was given a subacromial injection triamcinolone.
After a single injection into the subacromial space, the patients were instructed to perform home physical therapy and follow-up in four weeks. Each patient was evaluated in terms of arc of motion, Visual Analog Scale and the UCLA Shoulder Rating Scale.
The outcome measures were taken at the preinjection state, immediately post injection, and at 4 weeks follow-up.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01449448
|United States, Washington|
|Madigan Healthcare System|
|Tacoma, Washington, United States, 98327|